the prevalence of pain in patients attending sarcoma outpatient clinics疼痛患者的患病率参加肉瘤门诊.pdfVIP

Hindawi Publishing Corporation Sarcoma Volume 2011, Article ID 813483, 6 pages doi:10.1155/2011/813483 Research Article The Prevalence of Pain in Patients Attending Sarcoma Outpatient Clinics P. Y. Kuo, J. T. C. Yen, G. M. Parker, S. Chapman, S. Kandikattu, I. Sohanpal, Y. Barbachano, and J. E. Williams The Royal Marsden, NHS Foundation Trust, London SW3 6JJ, UK Correspondence should be addressed to J. E. Williams, john.williams@rmh.nhs.uk Received 19 January 2011; Accepted 10 March 2011 Academic Editor: Alessandro Gronchi Copyright © 2011 P. Y. Kuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The prevalence of pain in patients with sarcoma is not well documented. We investigated this in outpatients at a tertiary cancer referral centre, assessing the adequacy of pain control and for risk factors leading to higher prevalence and severity of pain. 149 patients were surveyed. Patients with pain within the previous 7 days completed pain assessment tools (BPI, S-LANSS, PMI). 53% of patients had pain within the previous 7 days, and 25% had significant pain. Of those with pain, 63% was inadequately controlled and neuropathic pain was identified in 36%. Age, gender, tumour type, and the type of cancer treatment were not significant predictors of the prevalence or severity of the pain. Based on our results, patients with sarcoma should be actively screened for pain and have regular reviews of their analgesic requirements. 1. Introduction With regards to pain prevalence related specifically to